Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor

Area of Science:

• Cardiology
• Molecular Biology
• Cell Biology

Background:

• The cellular and molecular pathways translating mechanical stimuli into cardiac muscle growth remain unclear, despite known hemodynamic influences on cardiac hypertrophy.
• Trophic factors released by cardiac cells may mediate autocrine or paracrine signaling, influencing neighboring cell growth and phenotype.
• Specific factors like Angiotensin II (via AT1 receptor), basic fibroblast growth factor, and heparin-binding epidermal growth factor show hypertrophic effects in vivo and in vitro.

Framework:

• Investigating the role of autocrine and paracrine signaling in cardiac hypertrophy.
• Identifying key trophic factors involved in the mechanical stress response of cardiac myocytes.
• Elucidating the molecular mechanisms linking mechanical load to growth factor release and cellular response.

Implementation:

• Studies demonstrate that Angiotensin II, basic fibroblast growth factor, and heparin-binding epidermal growth factor induce hypertrophic actions.
• Cardiac myocytes are shown to release these cytokines in response to increased mechanical load.
• This suggests an endogenous signaling system within the heart mediating adaptive growth.

Implications:

• Understanding these mechanisms is crucial for developing targeted therapies for cardiac hypertrophy and related heart diseases.
• This research provides insights into the complex interplay between mechanical forces and molecular signaling in the heart.
• Further research can explore the therapeutic potential of modulating these specific growth factor pathways.